Literature DB >> 6095517

Serological studies of parainfluenza type 3 virus, bovine adenovirus type 3 and bovine respiratory syncytial virus infection in beef calves.

D W Key, J B Derbyshire.   

Abstract

Six serum samples were taken at monthly intervals from birth to weaning from each of 41 newborn calves in the autumn and spring calf crops of a beef cow--calf herd. The serum hemagglutination-inhibition (HI) antibody titres to parainfluenza type 3 virus (PIV-3), virus-neutralization (VN) antibody titres to bovine adenovirus type 3 (BAV-3) and bovine respiratory syncytial virus (BRSV) were determined using microtitration techniques. There was serological evidence of a significantly higher incidence of infection with BAV-3 in the fall calves than in the spring calves. Serological responses to BAV-3 were not detected in calves with VN titres of greater than 1/256. Serological evidence of subclinical infection with PIV-3 occurred mainly in late February or early March during a period of marked environmental temperature fluctuations. Serological evidence of a high incidence of infection with BRSV was obtained for both the fall and spring calf crops. Serum antibody appeared to be unable to prevent infection with BRSV. An association between infection with BRSV and clinical pneumonia was found in 3 out of 9 calves. BAV-3 infection was related to pneumonia in only 1 instance; however, there was simultaneous evidence of BRSV infection in this calf. PIV-3 infection was found to be related to pneumonia in only 1 instance. There was serological evidence of infection with BAV-3 in association with the occurrence of diarrhea in 3 calves.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6095517     DOI: 10.1016/0378-1135(84)90021-x

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  9 in total

Review 1.  Immunity to human and bovine respiratory syncytial virus.

Authors:  T G Kimman; F Westenbrink
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

2.  Bovine herpesvirus-1 and parainfluenza-3 virus interactions: clinical and immunological response in calves.

Authors:  A Ghram; P G Reddy; J L Morrill; F Blecha; H C Minocha
Journal:  Can J Vet Res       Date:  1989-01       Impact factor: 1.310

3.  Comparisons of the F and HN gene sequences of different strains of bovine parainfluenza virus type 3: relationship to phenotype and pathogenicity.

Authors:  M M Breker-Klassen; D Yoo; L A Babiuk
Journal:  Can J Vet Res       Date:  1996-07       Impact factor: 1.310

4.  Application of a modified indirect fluorescent antibody test to the detection of antibodies to bovine respiratory syncytial virus in Ontario cattle.

Authors:  J A Lynch; J B Derbyshire
Journal:  Can J Vet Res       Date:  1986-07       Impact factor: 1.310

5.  Recombinant type 5 adenoviruses expressing bovine parainfluenza virus type 3 glycoproteins protect Sigmodon hispidus cotton rats from bovine parainfluenza virus type 3 infection.

Authors:  M M Breker-Klassen; D Yoo; S K Mittal; S D Sorden; D M Haines; L A Babiuk
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

6.  Association of bovine viral diarrhea virus with multiple viral infections in bovine respiratory disease outbreaks.

Authors:  L Richer; P Marois; L Lamontagne
Journal:  Can Vet J       Date:  1988-09       Impact factor: 1.008

7.  Bovine respiratory syncytial virus infection in an ontario cattle herd.

Authors:  J A Lynch; M G Maxie; D W Key; J B Hancey
Journal:  Can Vet J       Date:  1985-02       Impact factor: 1.008

8.  Serological studies of infectious bovine rhinotracheitis, parainfluenza 3, bovine viral diarrhea, and bovine respiratory syncytial viruses in calves following entry to a bull test station.

Authors:  P J Durham; L E Hassard; J Van Donkersgoed
Journal:  Can Vet J       Date:  1991-07       Impact factor: 1.008

9.  Exposure to novel parainfluenza virus and clinical relevance in 2 bottlenose dolphin (Tursiops truncatus) populations.

Authors:  Stephanie Venn-Watson; Rebecca Rivera; Cynthia R Smith; Jeremiah T Saliki; Shannon Caseltine; Judy St Leger; Pam Yochem; Randall S Wells; Hendrik Nollens
Journal:  Emerg Infect Dis       Date:  2008-03       Impact factor: 6.883

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.